Umbilical cord stem cells

Why bank your baby’s umbilical cord stem cells?

Collecting stem cells contained in the blood and tissue from your baby’s umbilical cord is a once-in-a lifetime opportunity. Cells collected during childbirth are the youngest that can be preserved, and haven’t yet aged. The potential of these cells is enormous thanks to their powerful ability to differentiate (into various cell types) and replicate (self-renew indefinately). Thanks to this umbilical cord stem cells can be used both to treat serious blood diseases with hematopoietic cells (HSC) and to treat pathologies and injuries, with mesenchymal cells (MSC) found in the cord tissue.

Which cells are collected?

The umbilical cord contains two different types of cells that are collected at birth:

These cells found in the blood of the umbilical cord and form part of our immune system. They have been used for more than 30 years to treat serious haematological diseases such as leukemias, lymphomas, anemias …

Some data on umbilical cord blood cells

  • + 30 YEARS: More than 30 years ago, in 1988, Dra. Gluckman performed the first umbilical cord blood transplant in Paris to treat Fanconi’s Anemia.
  • +85 DIFFERENT DISEASES: More than 85 different diseases are now treated with hematopoietic umbilical cord blood cells.
  • +40,000 TRANSPLANTS: Umbilical cord blood has been used more than 40,000 times for transplant patients with very positive results savings many lives.
  • + 400 CLINICAL TRIALS: Currently, there are more than 400 hematopoietic cell clinical trials underway worldwide. (clinical trials “umbilical cord blood”).

These are the cells found in the tissue of the umbilical cord and are the creators of the tissues and organs of our body. They are currently studying hundreds of different diseases across diverse medical specialties …

About umbilical cord tissue cells

  • Currently, mesenchymal stem cells are the most studied cell type in regenerative medicine.
  • More than 150 Clinical Trials
  • They have an immunomodulatory effect and multiline differentiation.
  • They have very diverse clinical applications, with bearing in a wide range of diseases.
Cèl·lules-mare-del-cordó-Cellab

How is the umbilical cord collected?

After your baby is born, the gynecologist handles the process of collecting the umbilical cord and introduces the biological material into a kit provided by Cellab, the CellabKit. We will deliver this kit to you at home before the birth and on the big day you take it with you to Hospital Nostra Senyora de Meritxell.

The blood from the cord is placed in a sterile bag and the cord tissue is stored in a sterile container. The samples are then sent to our laboratory located in Sant Julià de Lòria where they are processed and prepared for conservation.

30 years of conservation

When the samples arrive at Cellab they are transferred to the clean rooms of our laboratory and quickly processed. Once we have verified that they are sterile and have passed all the quality control checks, we freeze them at -180ºC using liquid nitrogen.

This cryopreservation allows us to stop the biological clock of the cells and preserve them for 30 years maintaining them at their point of maximum regenerative potential (year 0).

Reasons to store umbilical cord stem cells

COMPATIBILITY

They are 100% compatible with the baby and very compatible with other family members (siblings).

SINGLE MOMENT

Childbirth is the only time you can collect them. In this moment the stem cells are at their best as they have not aged.

PRESENT AND FUTURE

Stem cells are used to treat more than 85 different diseases and year by year their uses and the medical conditions they can be applied to increase.

GREATER POST-TRANSPLANT SURVIVAL

Having very close (own) blood or that of a related donor clearly improves the likelihood of success with a hematopoietic transplant.

GUARANTEED AVAILABILITY

Keeping the sample in a private bank gives the donor and the family the opportunity to have the sample with maximum availability.

Regenerative Medicine, a constantly growing market

Your decision to preserve your newborn baby’s umbilical cord stem cells will ensure your child access to their unique biological material for the future.

Medicine is evolving and exploring biological solutions that use a patient’s own cellular material. For this reason, storing umbilical cord cells provides the entry material for regenerative medicine.

  • +90 diseases treatable with stem cells

  • 123 clinical trials investigating umbilical cord blood

  • +40,000 transplants performed worldwide

  • 155 clinical trials investigating umbilical cord tissue

Diseases treatable with umbilical cord stem cells

The regenerative potential of cord stem cells is very significant.

  • ONCOLOGICAL DISEASES

  • Leukemias
  • Lymphomas
  • Sarcomas
  • Myeloma
  • AUTOIMMUNE DISEASES

  • Crohn’s disease
  • Evans syndrome
  • Autoimmune neutropenia
  • IMMUNODEFICIENCIES

  • DiGeorge’s Syndrome
  • Primary immunodeficiencies
  • MEDULLARY DEFICIENCIES

  • Anemias
  • Histiocytosis
  • Cytopenias
  • METABOLIC DISEASES

  • Anemias
  • Hemoglobinuria
  • MEDULLARY DEFICIENCIES

  • Syndromes
  • Leukodystrophies

Umbilical cord tissue is rich in mesenchymal cells. This type of cell gives rise to the structural and connective tissues of our body. Due to their ability to multiply and differentiate, mesenchymal cells are major protagonists in multiple clinical trials with amazing potential for a range of therapeutic applications.

Diseases where research utilising umbilical cord tissue cells has reached the clinical trial phase

Cartilage regeneration

SARS-CoV-2 – Covid19

Myocardial infarction

Critical limb ischemia

Multiple Sclerosis

Autism

Cerebral palsy

Crohn’s disease

COVID-19 Protocol

Since March 2020, Cellab has introduced a number of safety measures related to SARS-CoV-2 (COVID-19). We only process blood and umbilical cord tissue from pregnant women with negative PCR / TMA at the time of delivery.

If the pregnant woman tests positive for SARS-CoV-2 at the time of delivery, the service will be cancelled.

IMPORTANT INFORMATION: Once the pregnant woman is admitted to Hospital Nostra Senyora de Meritxell, a PCR or TMA test will be performed. The family must send a copy of the test result to Cellab.

Call us to request more information

Or send us a message here